MedTrace Logo

Efficacy and Saffety of Oral Immunotherapy to Pistachio

NCT05698030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-01-26

No results posted yet for this study

Summary

The objectives of this study are (i) to evaluate the efficacy of oral immunotherapy to pistachio by evaluating the daily oral tolerance of 2g pistachio, by evaluating the long-term tolerance of 15g pistachio (sustained unresponsiveness) and by decreasing pistachio-specific IgE, (ii) evaluating the efficacy of pistachio immunotherapy on cashew tolerance, (iii) and to evaluate the safety of pistachio immunotherapy.

Conditions

Interventions

OTHER

Food allergy

Oral immunotherapy to pistachio

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Amandine DIVARET-CHAUVEAU · Centre hospitalo-universitaire de Nancy

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2023-01-01
Completion
2023-01-16

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05698030 on ClinicalTrials.gov